Hepatitis B virus (HBV) is a major cause of chronic liver inflammation worldwide. Recent knowledge of the virological and immunological events secondary to HBV infection has increased our understanding of the mechanisms involved in viral clearance and persistence. In this review, how the early virological and immunological events might influence the development of a coordinate activation of adaptive immunity necessary to control HBV infection is analysed. The mechanism(s) by which high levels of viral antigens, liver immunological features, regulatory cells and dendritic cell defects might maintain the HBV-specific immunological collapse, typical of chronic hepatitis B patients, is also examined
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Hepatitis B virus (HBV) is a virus that infects about 350,000,000 people worldwide with a clinical s...
Chronic viral hepatitis infections are a major public health concern, with an estimated 290 million ...
Hepatitis B virus (HBV) induce various acute liver disease ranging from subclinical to fulminant hep...
Approximately 5% of the world population is infected by the hepatitis B virus (HBV) which causes a n...
textabstractClinical events and the host immune response during hepatitis B virus (HBV) infection ar...
Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans, HBV infec...
Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes and life-thre...
Approximately 5% of the world population is infected by the hepatitis B virus (HBV) that causes a ne...
Abstract Hepatitis B virus (HBV) infection has a low rate of chronicity compared to HC...
Hepatitis B virus (HBV) infections are among the major health problems and leading causes of cirrhos...
Hepatitis B virus (HBV) infection acquired in adult life is generally self-limited while chronic per...
Available information about the immune pathogenesis of HBV infection in man is very limited. However...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Hepatitis B virus (HBV) is a virus that infects about 350,000,000 people worldwide with a clinical s...
Chronic viral hepatitis infections are a major public health concern, with an estimated 290 million ...
Hepatitis B virus (HBV) induce various acute liver disease ranging from subclinical to fulminant hep...
Approximately 5% of the world population is infected by the hepatitis B virus (HBV) which causes a n...
textabstractClinical events and the host immune response during hepatitis B virus (HBV) infection ar...
Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans, HBV infec...
Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes and life-thre...
Approximately 5% of the world population is infected by the hepatitis B virus (HBV) that causes a ne...
Abstract Hepatitis B virus (HBV) infection has a low rate of chronicity compared to HC...
Hepatitis B virus (HBV) infections are among the major health problems and leading causes of cirrhos...
Hepatitis B virus (HBV) infection acquired in adult life is generally self-limited while chronic per...
Available information about the immune pathogenesis of HBV infection in man is very limited. However...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Hepatitis B virus (HBV) is a virus that infects about 350,000,000 people worldwide with a clinical s...
Chronic viral hepatitis infections are a major public health concern, with an estimated 290 million ...